Menu

Velocity Clinical Research - Gulfport, Mississippi

Gulfport, Mississippi United States

Claim This Site

Are you the site administrator? Claim this site to update information.

37Total Trials
1Recruiting Trials
7Active Trials
27Completed Trials
34Unique Conditions
28Unique Sponsors

Conditions

COVID-19 (5)SARS-CoV-2 Infection (5)Hypercholesterolemia (3)SARS-CoV-2 (3)Influenza, Human (2)Obesity (2)Pneumococcal Disease (2)Respiratory Tract Infection (2)

Sponsors

Pfizer (8)Merck Sharp & Dohme LLC (5)ModernaTX, Inc. (4)BioNTech SE (3)Novo Nordisk A/S (3)Seqirus (3)Eli Lilly and Company (2)Abbott Molecular (1)

Affiliations

Associated Organizations

Basic Information

Site Overview

Velocity's research site in Gulfport was founded in 2016 as the second site of MedPharmics and acquired by Velocity in 2022. Since its inception, the site has conducted trials in Infectious Diseases and Women’s Health, including over 25 vaccine trials. Our Gulfport site played an integral role during the height of the COVID-19 pandemic, completing COVID-19 trials for both children and adults. Located directly off Highway 49 in an independent medical office building on Dedeaux Road, the site is easily accessible with abundant parking. Additionally, the site is close to the local hospital. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Gulfport team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Accessibility & Parking

Accessibility Features

Wheelchair accessible entrance
Wheelchair accessible parking lot